Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Browse the complete record of transactions filed by Lerner Neil. Officer active across 1 company, notably Compass Therapeutics, Inc.. Aggregated, 4 reports have been published. Split: 2 buys · 0 sell. Total volume traded: €50k. Activity tracked since 7 April 2025. The latest transaction was disclosed on 29 April 2026 (Acquisition). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations
Lerner Neil is Chief Accounting Officer at Compass Therapeutics, Inc. (XNAS). He has 4 filings in total, and across the sampled recent filings between 2025-04-08 and 2026-04-30, buys total 50281 EUR and sells total 0 EUR, with the modal transaction nature listed as Acquisition.